DHX9 and neoplasm: A promising new compound is TK216, a small molecule that binds to EWS-FLI1, and by disrupting its interaction with RNA helicase A, it suppresses the downstream oncogenic transcriptional program to induce apoptosis and reduces tumor burden in Ewing’s sarcoma cell and xenograft models [48].